Consistent with the microarray data, we found a higher expression of HMGCS1 (3.5-fold), HMGCR (2.5-fold), SCD1 (2.5-fold), AGPS (1.9-fold), FABP4 (2.5-fold), DPT (2.2- fold), and PTEN (1.56-fold decline) in prostate tumors of LPB-Tag genotype when compared with the prostates of other genotypes. Here, HMGCS1 is linked to prostate neoplasm.